Finance

Beta
Lists
10V:FRA
Immunic Inc
€11.55
-5.25%
(-0.64) 1D
Jun 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 10V...
Open
€12.20
High
€12.66
Low
€11.55
Mkt. cap
173.95M
Avg. vol.
159.00
Volume
140.00
52-wk high
€13.00
52-wk low
€7.76
No. of employees
92
Open
€12.20
High
€12.66
Low
€11.55
Mkt. cap
173.95M
Avg. vol.
159.00
Volume
140.00
52-wk high
€13.00
52-wk low
€7.76
No. of employees
92
News stories
From sources across the web
About Immunic Inc
CEODaniel Vitt
Employees92
FoundedMay 2003
Headquarters-
SectorBiotechnology
Websiteimux.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.37M
20.01M
19.07M
25.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.71M
5.98M
4.26M
7.61M
Operating expense
27.08M
25.99M
23.33M
33.24M
Total operating expenses
27.08M
25.99M
23.33M
33.24M
Operating income
-27.08M
-25.99M
-23.33M
-33.24M
Other non operating income
22.00K
-5.00K
5.53M
-113.00K
EBT including unusual items
-26.82M
-25.58M
-19.30M
-32.59M
EBT excluding unusual items
-26.82M
-25.58M
-17.60M
-32.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.82M
-25.58M
-19.30M
-32.59M
Net profit margin
-
-
-
-
Earnings per share
-2.00
-1.30
-0.70
-1.08
Interest and investment income
241.00K
419.00K
197.00K
760.00K
Interest expense
-
-
-
-
Net interest expenses
241.00K
419.00K
197.00K
760.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.04M
-25.95M
-23.28M
-33.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer